Status:
RECRUITING
Evaluation of CMV/EBV-CMI in Haploid HSCT
Lead Sponsor:
The First Affiliated Hospital of Soochow University
Conditions:
Hematopoietic Stem Cell Transplantation
Cytomegalovirus Infections
Eligibility:
All Genders
16-60 years
Brief Summary
The purpose of this prospective, open-label, Single Arm, single-center study is to evaluate the cytomegalovirus and Epstein-Barr virus specific immune reestablishment for patients with hemopathy under...
Eligibility Criteria
Inclusion
- All patients were diagnosed with hemopathy.
- All patients should have the indication of Haploidentical hematopoietic stem cell transplant and receive the prophylaxis for cytomegalovirus.
- All patients should sign an informed consent document indicating that they understand the purpose of and procedures required for the study and be willing to participate in the study.
Exclusion
- Patients with any conditions not suitable for the trial (investigators' decision).
Key Trial Info
Start Date :
August 13 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06554197
Start Date
August 13 2024
End Date
July 31 2026
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China, 215006